<DOC>
	<DOCNO>NCT00214721</DOCNO>
	<brief_summary>Objective : The purpose study demonstrate : -the non-inferiority experimental peritoneal dialysis solution compare current solution management end stage renal disease ( ESRD ) peritoneal dialysis patient .</brief_summary>
	<brief_title>A Study Evaluate Efficacy Safety Experimental Solution Peritoneal Dialysis</brief_title>
	<detailed_description />
	<mesh_term>Kidney Failure , Chronic</mesh_term>
	<mesh_term>Pharmaceutical Solutions</mesh_term>
	<mesh_term>Dialysis Solutions</mesh_term>
	<criteria>Patients give write informed consent nature study explain . Patients least 18 year age . Patients treat CAPD use specific solution least 60 day baseline visit . Patients receive antibiotic treatment episode peritonitis within 30 day screen visit . Patients acute chronic exitsite tunnel infection past 14 day , count last day infection screen visit . Patients serious disease , active , previously treat , residual malignancy systemic infection . Patients major illness injury require hospitalisation within 30 day baseline visit . Patients severe malnutrition ( serum albumin &lt; 25 g/l bromocresol green method ) . Patients participate another study require Ethics Committee approval . Noninterventional study permit . Patients receive investigational product within 30 day precede screen visit . Patients pregnant lactating . ( NB : Female patient childbearing potential must negative urine serum pregnancy test time screening require use medically acceptable mean contraception participation study ) . Patients significant psychiatric disorder mental disability could interfere his/her ability provide inform consent and/or comply protocol procedure .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>November 2007</verification_date>
</DOC>